Matches in SemOpenAlex for { <https://semopenalex.org/work/W2172537787> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2172537787 endingPage "651" @default.
- W2172537787 startingPage "646" @default.
- W2172537787 abstract "Tertiary hyperparathyroidism (3°HPT) is defined as persistent hyperparathyroidism with hypercalcemia after renal transplantation. Near total parathyroidectomy (NTPTX) is the current standard for surgical intervention. The purpose of this study was to identify outcomes of NTPTX. A retrospective review was conducted of surgeries performed between 1994 and 2013. NTPTX resulted in resolution of 96.9 per cent of patients’ hypercalcemia at a median follow-up of three years (interquartile range [IQR], 1 to 8). However, 3.1 per cent of patients remained hypercalcemic with a mean calcium of 10.5 ± 0.2 mg/dL. A total of 78.4 per cent of patients had parathyroid hormone (PTH) levels below 250 pg/mL at a median follow-up of two years (IQR, 2 to 8). The remaining 21.6 per cent had a median PTH of 535 (IQR, 345 to 857). PTH levels dropped from a median of 745 (IQR, 285.75 to 1594.25) pg/mL to 97 (IQR, 60 to 285) pg/mL one month post-NTPTX ( P < 0.01). The most frequent complication was transient hypocalcemia in 27.1 per cent of patients, but no patients became permanently hypocalcemic. In the 1-month postoperative period, only one patient had a cardiac complication, and there was 0 per cent all-cause mortality. Glomerular filtration rate fell from 57.9 ± 28.3 mL/min pre-NTPTX to 53.2 ± 27.5 mL/min at 1-year post-NTPTX ( P < 0.01). NTPTX effectively treats hypercalcemia in 3°HPT. However, PTH remains elevated (greater than 250) in 21.6 per cent of patients." @default.
- W2172537787 created "2016-06-24" @default.
- W2172537787 creator A5028065640 @default.
- W2172537787 creator A5031306259 @default.
- W2172537787 creator A5040146753 @default.
- W2172537787 date "2014-07-01" @default.
- W2172537787 modified "2023-09-23" @default.
- W2172537787 title "Near Total Parathyroidectomy is Effective Therapy for Tertiary Hyperparathyroidism" @default.
- W2172537787 cites W1965177810 @default.
- W2172537787 cites W1975398760 @default.
- W2172537787 cites W1976524871 @default.
- W2172537787 cites W1978355780 @default.
- W2172537787 cites W2004909647 @default.
- W2172537787 cites W2005280280 @default.
- W2172537787 cites W2011031868 @default.
- W2172537787 cites W2022890761 @default.
- W2172537787 cites W2039386621 @default.
- W2172537787 cites W2044628282 @default.
- W2172537787 cites W2062010471 @default.
- W2172537787 cites W2063358358 @default.
- W2172537787 cites W2082801649 @default.
- W2172537787 cites W2134496271 @default.
- W2172537787 cites W2144419439 @default.
- W2172537787 doi "https://doi.org/10.1177/000313481408000717" @default.
- W2172537787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24987894" @default.
- W2172537787 hasPublicationYear "2014" @default.
- W2172537787 type Work @default.
- W2172537787 sameAs 2172537787 @default.
- W2172537787 citedByCount "12" @default.
- W2172537787 countsByYear W21725377872015 @default.
- W2172537787 countsByYear W21725377872016 @default.
- W2172537787 countsByYear W21725377872017 @default.
- W2172537787 countsByYear W21725377872018 @default.
- W2172537787 countsByYear W21725377872019 @default.
- W2172537787 crossrefType "journal-article" @default.
- W2172537787 hasAuthorship W2172537787A5028065640 @default.
- W2172537787 hasAuthorship W2172537787A5031306259 @default.
- W2172537787 hasAuthorship W2172537787A5040146753 @default.
- W2172537787 hasBestOaLocation W21725377871 @default.
- W2172537787 hasConcept C119060515 @default.
- W2172537787 hasConcept C126322002 @default.
- W2172537787 hasConcept C126894567 @default.
- W2172537787 hasConcept C141071460 @default.
- W2172537787 hasConcept C167135981 @default.
- W2172537787 hasConcept C2775945674 @default.
- W2172537787 hasConcept C2776096700 @default.
- W2172537787 hasConcept C2777645128 @default.
- W2172537787 hasConcept C2778838027 @default.
- W2172537787 hasConcept C2781208988 @default.
- W2172537787 hasConcept C519063684 @default.
- W2172537787 hasConcept C71924100 @default.
- W2172537787 hasConcept C81182388 @default.
- W2172537787 hasConceptScore W2172537787C119060515 @default.
- W2172537787 hasConceptScore W2172537787C126322002 @default.
- W2172537787 hasConceptScore W2172537787C126894567 @default.
- W2172537787 hasConceptScore W2172537787C141071460 @default.
- W2172537787 hasConceptScore W2172537787C167135981 @default.
- W2172537787 hasConceptScore W2172537787C2775945674 @default.
- W2172537787 hasConceptScore W2172537787C2776096700 @default.
- W2172537787 hasConceptScore W2172537787C2777645128 @default.
- W2172537787 hasConceptScore W2172537787C2778838027 @default.
- W2172537787 hasConceptScore W2172537787C2781208988 @default.
- W2172537787 hasConceptScore W2172537787C519063684 @default.
- W2172537787 hasConceptScore W2172537787C71924100 @default.
- W2172537787 hasConceptScore W2172537787C81182388 @default.
- W2172537787 hasIssue "7" @default.
- W2172537787 hasLocation W21725377871 @default.
- W2172537787 hasLocation W21725377872 @default.
- W2172537787 hasOpenAccess W2172537787 @default.
- W2172537787 hasPrimaryLocation W21725377871 @default.
- W2172537787 hasRelatedWork W1968743894 @default.
- W2172537787 hasRelatedWork W1987227128 @default.
- W2172537787 hasRelatedWork W2049768212 @default.
- W2172537787 hasRelatedWork W2090027054 @default.
- W2172537787 hasRelatedWork W2092666585 @default.
- W2172537787 hasRelatedWork W2123891062 @default.
- W2172537787 hasRelatedWork W3020885945 @default.
- W2172537787 hasRelatedWork W3029189552 @default.
- W2172537787 hasRelatedWork W3049581462 @default.
- W2172537787 hasRelatedWork W3112686011 @default.
- W2172537787 hasVolume "80" @default.
- W2172537787 isParatext "false" @default.
- W2172537787 isRetracted "false" @default.
- W2172537787 magId "2172537787" @default.
- W2172537787 workType "article" @default.